Law Firms

South Korean biosimilars company Samsung Bioepis has sued Johnson & Johnson’s Janssen Biotech to invalidate two patents for Crohn’s disease drug Stelara, after reaching a licencing agreement over the medicine in the US.

Health law practitioners are grappling with “snowballing awards” in claims over psychiatric injuries, according to Sparke Helmore’s new health law partner. 

A Melbourne orthopaedic clinic has lost its bid to register the name ‘Melbourne Bone and Joint Clinic’ as a trade mark, with a judge finding the phrase was just an ordinary combination of words. 

It’s a case of déjà vu in a class action against engineering services company Worley, with shareholders heading back to the appeals court after losing a second trial in their drawn out fight over disclosure breaches.

Sydney financier First Class Capital has admitted it acquired three million shares in former market darling Big Un but has denied liquidators’ claims that the purchase was part of a fraudulent design to inflate the share price ahead of the video start-up’s collapse.

Online broker International Capital Markets has been hit with a second class action for selling “excessively risky” derivative products known as contracts for difference to retail investors. 

Car repair giant AMA Group has resolved its case against three former executives that sought to block them from poaching staff and customers for competing business Drive Group. 

Telstra has won its bid to vacate a hearing in a case by former contractor Kingfisher Mobile seeking to bar the telco from migrating customers to a new mobile services provider, after a judge found Kingfisher’s delay in filing the case meant meeting the date would be unfair. 

Practitioners have marked the passing of former NSW Supreme Court Justice Andrew Rogers KC, who will be remembered for transforming commercial litigation through his vigorous, often “brutal” approach to case management.

A judge has signed off on a 27.5 per cent group costs order in a consolidated shareholder class action against Medibank over a cyberattack that affected 10 million customers, noting the “significant risk” taken on by the two plaintiff law firms running the action.